Wordt geladen...
AXL Mediates TRAIL Resistance in Esophageal Adenocarcinoma
The overexpression of AXL receptor tyrosine kinase is a frequent finding that has been associated with poor prognosis in esophageal adenocarcinoma (EAC). As the majority of EAC are intrinsically resistant to DNA-damaging therapies, an alternative therapeutic approach based on the activation of death...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Neoplasia Press Inc.
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3593152/ https://ncbi.nlm.nih.gov/pubmed/23479507 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|